STOCK TITAN

Iqvia Hldgs Inc - IQV STOCK NEWS

Welcome to our dedicated page for Iqvia Hldgs news (Ticker: IQV), a resource for investors and traders seeking the latest updates and insights on Iqvia Hldgs stock.

IQVIA Holdings Inc. (IQV) delivers integrated healthcare insights through its unique combination of clinical research expertise and advanced data analytics. This news hub provides investors and industry professionals with timely updates on corporate developments shaping the life sciences sector.

Access official press releases and curated news coverage spanning clinical trial milestones, healthcare data partnerships, regulatory updates, and technology innovations. Our collection serves as a strategic resource for understanding IQVIA's role in optimizing drug development cycles and commercial decision-making.

Key content categories include earnings announcements, merger/acquisition activity, leadership changes, and analytical breakthroughs in real-world evidence applications. Bookmark this page for efficient tracking of IQVIA's progress in transforming clinical research through data-driven solutions.

Rhea-AI Summary
Patient organizations contribute $22.2 billion in grants over the past 5 years, according to a report by IQVIA Institute for Human Data Science.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
none
-
Rhea-AI Summary
IQVIA announces strategic collaboration with argenx to advance treatment for rare autoimmune diseases through innovative technology-enabled pharmacovigilance (PV) safety services and solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.62%
Tags
none
-
Rhea-AI Summary
IQVIA appoints Richard Staub III as president of its Research & Development Solutions (R&DS) business unit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.7%
Tags
management
Rhea-AI Summary
IQVIA named Leader in IDC Marketscape Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
-
Rhea-AI Summary
Ron Bruehlman, CFO of IQVIA, will speak at the Baird 2023 Global Healthcare Conference on Sep 13, 2023. Webcast available on IQVIA Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.53%
Tags
conferences
-
Rhea-AI Summary
IQVIA CEO to speak at Morgan Stanley Annual Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
conferences
Rhea-AI Summary
IQVIA Holdings Inc. reported Q2 2023 financial results with revenue of $3,728 million, a 5.3% YoY increase. GAAP Net Income grew 16.0% YoY to $297 million. R&D Solutions quarterly bookings reached $2.7 billion with a book-to-bill ratio of 1.28x. The contracted backlog grew 11% YoY to $28.4 billion. IQVIA expects approximately $7.3 billion of the backlog to convert to revenue in the next twelve months.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.07%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
none
Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

IQV Stock Data

25.37B
174.77M
0.88%
95.89%
1.99%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM